Introduction Peptide Vilon, known scientifically as lysylglutamic acid or Lys-Glu, is a groundbreaking dipeptide that’s gaining recognition in bioregulatory and gerontological research. Its potential applications span immunomodulation, anti-ageing, and cancer treatment. This comprehensive guide provides a detailed overview of Peptide Vilon, encompassing its structure, functionality, and potential applications.
Understanding Peptide Vilon
What is Peptide Vilon? Peptide Vilon is a synthetic dipeptide, unique for its minimal length yet significant biological activity. It has become the focus of numerous studies due to its potential to enhance tissue regeneration, immune function, and ageing processes.
The Science Behind Peptide Vilon
Molecular Composition and Structure With the molecular formula C11H21N3O5 and a molecular weight of 257.30 g/mol, Vilon stands out as the shortest peptide with known biological activity. Its structure facilitates interaction with cellular components, allowing effective bioregulatory functions.
Regenerative and Immunomodulatory Effects Vilon’s primary role involves regeneration and immunomodulation. It aids in tissue regeneration and wound healing, making it a promising candidate for studies on healing and cellular repair.
Peptide Vilon in Aging and Immune Function
Anti-Aging Properties Vilon is noted for its anti-ageing effects. Research suggests it improves health and longevity, indicating a potential role in slowing down ageing at the cellular level.
Vilon and Cancer Research
Role in Cancer Prevention and Treatment Vilon shows promise in cancer research, acting as a chemotherapeutic agent and possibly aiding in both cancer prevention and supplemental treatment.
Dosage and Administration Guidelines for Research Use
Recommended Research Dosage For research, Vilon is typically administered subcutaneously at 5mg per day over a 12-day cycle, repeated every four to six months. Approximately three 20mg vials are needed for a 10-day cycle.
Potential Cardiovascular and Renal Benefits
Cardiovascular System Impact Emerging studies suggest benefits for the cardiovascular system, including the potential alteration of gene expression in the heart.
Renal Function Enhancement Vilon may improve kidney health, especially in chronic renal failure, by affecting transforming growth factor-beta and microvessel permeability.
Peptide Vilon in Human Health and Longevity
Enhancing Physical Activity and Endurance Vilon’s role in improving physical activity, endurance, and GI function underlines its potential to enhance quality of life and extend lifespan.
Research and Development Contributions
Notable Scientific Contributions Scientists like Dr Vladimir Anisimov and Vladimir Khavinson have significantly contributed to the development of Peptide Vilon, particularly in ageing and cancer research.
Legal and Ethical Considerations
Usage Restrictions Vilon is intended for in-vitro studies and educational purposes only, not approved for human or animal consumption.
Conclusion
Future Prospects and Applications Peptide Vilon offers a wide range of potential applications in bioregulation, gerontology, and beyond. As research continues, it may provide groundbreaking insights into ageing, immune regulation, and cancer treatment.
For more detailed information, including specific studies and scientific analyses, refer to relevant scientific publications and research databases.
Disclaimer: The information is based on current scientific research and is intended for educational and research purposes only.